These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 21673124)

  • 1. Evaluating the incremental value of new biomarkers with integrated discrimination improvement.
    Kerr KF; McClelland RL; Brown ER; Lumley T
    Am J Epidemiol; 2011 Aug; 174(3):364-74. PubMed ID: 21673124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the incremental predictive performance of novel biomarkers over standard predictors.
    Xanthakis V; Sullivan LM; Vasan RS; Benjamin EJ; Massaro JM; D'Agostino RB; Pencina MJ
    Stat Med; 2014 Jul; 33(15):2577-84. PubMed ID: 24719270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The power-integrated discriminant improvement: An accurate measure of the incremental predictive value of additional biomarkers.
    Hayashi K; Eguchi S
    Stat Med; 2019 Jun; 38(14):2589-2604. PubMed ID: 30859601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymptotic distribution of ∆AUC, NRIs, and IDI based on theory of U-statistics.
    Demler OV; Pencina MJ; Cook NR; D'Agostino RB
    Stat Med; 2017 Sep; 36(21):3334-3360. PubMed ID: 28627112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Net Reclassification Index and Integrated Discrimination Index Are Not Appropriate for Testing Whether a Biomarker Improves Predictive Performance.
    Burch PM; Glaab WE; Holder DJ; Phillips JA; Sauer JM; Walker EG
    Toxicol Sci; 2017 Mar; 156(1):11-13. PubMed ID: 27815493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A note on the evaluation of novel biomarkers: do not rely on integrated discrimination improvement and net reclassification index.
    Hilden J; Gerds TA
    Stat Med; 2014 Aug; 33(19):3405-14. PubMed ID: 23553436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inference for reclassification statistics under nested and non-nested models for biomarker evaluation.
    Shao F; Li J; Fine J; Wong WK; Pencina M
    Biomarkers; 2015; 20(4):240-52. PubMed ID: 26301882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interpreting incremental value of markers added to risk prediction models.
    Pencina MJ; D'Agostino RB; Pencina KM; Janssens AC; Greenland P
    Am J Epidemiol; 2012 Sep; 176(6):473-81. PubMed ID: 22875755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.
    Vernooij LM; van Klei WA; Moons KG; Takada T; van Waes J; Damen JA
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD013139. PubMed ID: 34931303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of reclassification statistics in comparing risk prediction models.
    Cook NR; Paynter NP
    Biom J; 2011 Mar; 53(2):237-58. PubMed ID: 21294152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simpson's paradox in the integrated discrimination improvement.
    Chipman J; Braun D
    Stat Med; 2017 Dec; 36(28):4468-4481. PubMed ID: 29160558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicategory reclassification statistics for assessing improvements in diagnostic accuracy.
    Li J; Jiang B; Fine JP
    Biostatistics; 2013 Apr; 14(2):382-94. PubMed ID: 23197381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New metrics for assessing diagnostic potential of candidate biomarkers.
    Pickering JW; Endre ZH
    Clin J Am Soc Nephrol; 2012 Aug; 7(8):1355-64. PubMed ID: 22679181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKD.
    Edmonston D; Wojdyla D; Mehta R; Cai X; Lora C; Cohen D; Townsend RR; He J; Go AS; Kusek J; Weir MR; Isakova T; Pencina M; Wolf M;
    Am J Kidney Dis; 2019 Dec; 74(6):771-781. PubMed ID: 31445926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing for improvement in prediction model performance.
    Pepe MS; Kerr KF; Longton G; Wang Z
    Stat Med; 2013 Apr; 32(9):1467-82. PubMed ID: 23296397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of polygenic risk models using multiple performance measures: a critical assessment of discordant results.
    Martens FK; Tonk ECM; Janssens ACJW
    Genet Med; 2019 Feb; 21(2):391-397. PubMed ID: 29895851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the assessment of the added value of new predictive biomarkers.
    Chen W; Samuelson FW; Gallas BD; Kang L; Sahiner B; Petrick N
    BMC Med Res Methodol; 2013 Jul; 13():98. PubMed ID: 23895587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Bayesian framework for estimating the incremental value of a diagnostic test in the absence of a gold standard.
    Ling DI; Pai M; Schiller I; Dendukuri N
    BMC Med Res Methodol; 2014 May; 14():67. PubMed ID: 24886359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating a New Risk Marker's Predictive Contribution in Survival Models.
    Liu M; Kapadia AS; Etzel CJ
    J Stat Theory Pract; 2010 Dec; 4(4):845-855. PubMed ID: 22984361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.